Ex parte WANG - Page 3




                Appeal No. 1997-0094                                                                                                           
                Application No. 08/188,232                                                                                                     


                Ishimura et al. (Ishimura), "Antigenic Specificity of a Rabbit Antiserum Raised Against the                                    
                15-28 Segment of Thymosin " ," Molecular Immunology, Vol. 23, No. 7, pp. 701-707                                               
                                                       1                                                                                       
                (1986).                                                                                                                        
                Abiko et al. (Abiko I), "Synthesis of an Immunologically Active Fragment Analog of                                             
                Prothymosin " with Enhanced Enzymatic Stability,"  Chemical & Pharmaceutical Bulletin,                                         
                Vol. 39, No. 3 pp. 752-756 (March 1991).                                                                                       
                                                                   ISSUE                                                                       
                         Claims 1, 4 and 7 stand rejected under 35 U.S.C. § 103 as being unpatentable over                                     
                either Haritos or Abiko I in view of any one of Abiko II or Zatz or Ishimura.                                                  
                         We REVERSE.                                                                                                           
                         Initially, we note that here the examiner required appellant "to elect a single                                       
                disclosed specie [sic] of the polypeptide and indicate claim(s) reading thereon or draw                                        
                claim(s) to the elected specie [sic]" (Paper No. 4, mailed March 29, 1994, p. 3).  Appellant,                                  
                in turn, elected "Group I, claims 1-7, and thymosin " -gly amide of Example 3, for                                             
                                                                                 1                                                             
                examination on the merits.  Claims 1, 4 and 7 are readable thereon." (Paper No. 6, filed                                       
                April 20, 1994).  Thus, the specific issue presented for review is whether the compound                                        
                thymosin " -gly amide would have been obvious under 35 U.S.C. § 103 in view of the prior                                       
                              1                                                                                                                
                art references cited and relied on by the examiner.  We discuss that single issue infra and                                    
                we take no position respecting the patentability of the remaining non-elected species.                                         






                                                                     - 3 -                                                                     





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007